Skip to main content
SearchLoginLogin or Signup

Reviews of "Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial"

Reviewers: S Vasan (Henry M Jackson Foundation) | 📘📘📘📘📘 • E Mills (McMaster University) | 📘📘📘📘📘

Published onAug 15, 2022
Reviews of "Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial"

To read the original manuscript, click the link above.

Summary of Reviews: This preprint evaluated the effectiveness of ivermectin in shortening symptom duration or preventing hospitalization in people with mild-moderate COVID-19 symptoms. Both reviewers are in agreement that this study provides strong support for its claim that ivermectin does not seem to provide any clinically significant improvement in treatment outcomes.

Reviewer 1 (Sandhya V) | 📘📘📘📘📘

Reviewer 2 (Edward M) | 📘📘📘📘📘

To read the reviews, click the links below. 


Comments
1
?
Jacintha Kyomi:

I appreciate your article as well as your research. However, it is a fact that we cannot completely eliminate Covid from human life. Therefore, preventive measures are extremely necessary and effective. For example, disinfecting hands, wearing masks when going out and staying at home to play donkey kong to prevent the spread of disease.